4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Arcturus Therapeutics Holdings Inc. (ARCT) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 106 employees. Its market capitalization is roughly $165 million. In the fiscal year ended 2025-12-31, ARCT reported $67M in revenue and ($66M) in net income.
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system.
Interactive charts & full statements → Open the ARCT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $67M | $138M | $158M | $206M | — |
| Operating Income (EBIT) | ($76M) | ($96M) | ($78M) | $12M | — |
| Net Income | ($66M) | ($81M) | ($30M) | $9M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $3M | $14M | $24M | $26M | — |
| Operating Income (EBIT) | ($29M) | ($31M) | ($16M) | ($12M) | ($17M) | — |
| Net Income | ($27M) | ($29M) | ($13M) | ($9M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $271M | $344M | $429M | $450M | — |
| Total Liabilities | $57M | $103M | $151M | $180M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ARCT viewer.
About TickerBase · Data methodology & sources